Loading...
XNAS
STKH
Market cap421kUSD
Oct 08, Last price  
0.60USD
1D
-1.49%
1Q
-67.07%
Name

Steakholder Foods Ltd

Chart & performance

D1W1MN
XNAS:STKH chart
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
98.67%
Rev. gr., 5y
-48.42%
Revenues
0
-100.00%
097,149356,258395,691245,72100314,320318,463410,28849,1210000010,0000
Net income
-11m
L+31.99%
00000000620,54800-3,129,259-18,532,000-18,042,000-21,773,471-16,864,000-8,521,000-11,247,000
CFO
-7m
L-20.25%
0000000042,37500-741,018-3,832,000-13,960,000-14,763,009-12,727,000-8,458,000-6,745,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

An innovative deep-tech food enterprise, MeaTech 3D Ltd. focuses on pioneering cultivated meat solutions to produce meat without the need for traditional animal slaughter. Central to its approach is the development of a proprietary 3D bioprinter, capable of intricately depositing layers of specialized stem cells, a supporting scaffold, and essential cell nutrients to construct structured, three-dimensional cultured meat. Its business model involves licensing this advanced production technology and supplying complementary products such as specific cell lines, printheads, bioreactors, and incubators. Additionally, MeaTech 3D will offer extensive services, including system integration, training programs, and ongoing engineering assistance, to food processing and retail businesses, delivered directly or via partnerships. The company's operations are based in Rehovot, Israel.

Key people

Yaron Kaiser
Non-Executive Chairman of the Board · since 2022
Chief Executive Officer · since 2022
Omri Schanin
Deputy Chief Executive Officer · since 2022
Guy Hefer
Chief Financial Officer · since 2020
Dan Kozlovski
Chief Technology Officer · since 2022
Non-Executive Independent Director · since 2018
Non-Executive Independent Director · since 2019
Non-Executive Independent Director · since 2021
IPO date
Aug 29, 1994
Employees
81
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT